Cite
Alonso CD, Kelly CP, Garey KW, et al. Ultrasensitive and quantitative toxin measurement correlates with baseline severity, severe outcomes, and recurrence among hospitalized patients with Clostridioides difficile infection. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab826.
Alonso, C. D., Kelly, C. P., Garey, K. W., Gonzales-Luna, A. J., Williams, D., Daugherty, K., Cuddemi, C., Villafuerte-Gálvez, J., White, N. C., Chen, X., Xu, H., Sprague, R., Barrett, C., Miller, M., Foussadier, A., Lantz, A., Banz, A., & Pollock, N. R. (2021). Ultrasensitive and quantitative toxin measurement correlates with baseline severity, severe outcomes, and recurrence among hospitalized patients with Clostridioides difficile infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab826
Alonso, Carolyn D, et al. "Ultrasensitive and quantitative toxin measurement correlates with baseline severity, severe outcomes, and recurrence among hospitalized patients with Clostridioides difficile infection." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab826
Alonso CD, Kelly CP, Garey KW, Gonzales-Luna AJ, Williams D, Daugherty K, Cuddemi C, Villafuerte-Gálvez J, White NC, Chen X, Xu H, Sprague R, Barrett C, Miller M, Foussadier A, Lantz A, Banz A, Pollock NR. Ultrasensitive and quantitative toxin measurement correlates with baseline severity, severe outcomes, and recurrence among hospitalized patients with Clostridioides difficile infection. Clin Infect Dis. 2021 Sep 19; doi: 10.1093/cid/ciab826. Epub 2021 Sep 19. PMID: 34537841.
Copy
Download .nbib